Don't care Zman cos it's a long term hold! Plenty of sales growth to be realised from UK and Ireland before France, Belgium and others kick in. Also, reduced cost of goods for Penthrox. I agree with your observation that profitability of respiratory business needs to be addressed.
Ann: Update - Dividend/Distribution - MVP, page-3
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.010(2.44%) |
Mkt cap ! $34.52M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 40.0¢ | $3.981K | 9.899K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 62022 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 815 | 2 |
View Market Depth
| Last trade - 15.59pm 04/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |